Furthermore, now that the shortage is over, the FDA may take action against compounding pharmacies that compound, distribute, or dispense compounded GLP-1s
[7] [1] Patients should be counselled to seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back, particularly if accompanied by nausea and vomiting
If youre taking one of these medications and notice digestive issues that persist or worsen, contact your healthcare provider promptly
So when you remove the GLP-1 medication, that patient is set back on a course of weight increase. In other words, without the medication to block and promote pathways that can affect a bodys biochemistry, a person is more likely to return to consuming more calories and regaining weight
Based on Obesity Canada guidelines and clinical trials (typically over ~1 year): Saxenda: ~58% total body weight loss Wegovy: ~1015% total body weight loss Tirzepatide: ~1520% (or more) total body weight loss weight loss is gradual and occurs over several months, with the most significant changes seen after reaching the full therapeutic dose results vary depending on adherence, lifestyle factors, and individual response 7
and pregnancy-specific liver diseases included HELLP syndrome, intrahepatic cholestasis of pregnancy, and acute fatty liver of pregnancy
